logo-loader
viewCollagen Solutions PLC

Collagen Solutions receives £1.54mln grant from Scottish government

Glasgow-based Collagen Solutions PLC (LON:COS) has been awarded a grant of up to £1.54mln from the Scottish government as part of plans to grow the life sciences sector in the country. Collagen CEO Jamal Rushdy and CFO Hilary Spence both explain to Proactive Investors London how significant this announcement is and what it means for the cash balance sheet. News here too on exactly which R&D projects will benefit and how critical this development is to Collagen's long term R&D programme.
The grant will cover more than a third of Collagen’s expected R&D costs – estimated to be in the region of £4mln – over the next three years.

Quick facts: Collagen Solutions PLC

Price: 3.55 GBX

LSE:COS
Market: LSE
Market Cap: £15.75 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Collagen Solutions PLC named herein, including the promotion by the Company of Collagen Solutions PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Collagen Solutions released financial number showing more...

Collagen Solutions (LON: COS) CEO Jamal Rushdy joined Steve Darling from Proactive to discuss the company releasing their financial numbers that show impressive double-digit sales growth.  Rushdy talks about the numbers and also their tissue division that continues to be a revenue driver.

on 23/10/19

2 min read